Destiny Pharma's nasal spray project already delivering - Neil Clark, CEO, Destiny Pharma 00:00:00

Share On Facebook Share On Twitter

Destiny Pharma PLC (AIM:DEST, OTC:DTTYF) CEO Neil Clark speaks to Proactive after releasing fresh data from the update from a research collaboration into a novel biotherapeutic treatment for COVID-19 and influenza.

Recent Videos